Low overexpression of HER-2/PPPNeu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin®) and irinotecan as therapy. A phase II trial

Ramesh K. Ramanathan, Jimmy J. Hwang, William C. Zamboni, Frank A. Sinicrope, Howard Safran, Michael K. Wong, Martin Earle, Adam Brufsky, Terry Evans, Monica Troetschel, Christine Walko, Roger Day, Helen X. Chen, Sydney Finkelstein

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Low overexpression of HER-2/PPPNeu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin®) and irinotecan as therapy. A phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences